Skip to main content

Harvey Jay Cohen

Walter Kempner Distinguished Professor of Medicine, in the School of Medicine
Medicine, Geriatrics and Palliative Care
Duke Box 3003, Durham, NC 27710
2509 Blue Zone Duke Clinic, Center for Aging, Trent Drive, Durham, NC 27710

Scholarly Works - Conferences


Association of opioid and benzodiazepine coprescribing with adverse events among older adults with cancer.

Conference J Natl Cancer Inst · July 1, 2025 BACKGROUND: Many older adults with cancer are coprescribed opioids/benzodiazepines; evidence on harms is lacking. METHODS: Using SEER-Medicare (2012-2019), we identified patients with breast, colorectal, or lung cancer. Cox proportional hazards models esti ... Full text Link to item Cite

Cognitive and Cerebrospinal Fluid Alzheimer's Disease-related Biomarker Trajectories in Older Surgical Patients and Matched Nonsurgical Controls.

Conference Anesthesiology · May 1, 2024 BACKGROUND: Anesthesia and/or surgery accelerate Alzheimer's disease pathology and cause memory deficits in animal models, yet there is a lack of prospective data comparing cerebrospinal fluid (CSF) Alzheimer's disease-related biomarker and cognitive traje ... Full text Link to item Cite

Falls and hospitalization during chemotherapy in older women with early breast cancer.

Conference Journal of Clinical Oncology · June 1, 2023 12035 Background: Hospitalizations are frequent, burdensome, and potentially avoidable complications of cancer treatment in older adults. While geriatric assessments can identify older patients at risk for hospitalization, the us ... Full text Cite

Associations of frailty with overall survival (OS) and functional decline among older adults with non–small-cell lung cancer (NSCLC) receiving chemotherapy, immunotherapy, and/or targeted therapy.

Conference Journal of Clinical Oncology · June 1, 2023 12040 Background: Among older adults with cancer receiving chemotherapy, frailty indices can predict poor outcomes including survival and toxicity. Given the increasing use of immunotherapy and targeted therapy to treat NSCLC, we ... Full text Cite

Abstract B111: Black-White differences in physical and cognitive aging among older breast cancer survivors in the Thinking and Living with Cancer Study

Conference Cancer Epidemiology, Biomarkers & Prevention · January 1, 2023 AbstractIntroduction: While some cancer survivors experience minimal lasting effects of diagnosis and treatment, others report persistent decrements in physical and cognitive function. These changes may repr ... Full text Cite

Abstract PD10-10: Factors associated with decreased relative dose intensity in older adults with early-stage breast cancer receiving chemotherapy

Conference Cancer Research · February 15, 2020 AbstractBackground: Older adults with breast cancer receiving neo/adjuvant chemotherapy are at increased risk for toxicity and dose reductions, often leading to decreased relative dose intensity (dRDI &l ... Full text Cite

Is objective mobility data associated with pharmacologic venous thromboembolism (VTE) prophylaxis use among hospitalized older adults?

Conference Journal of Hospital Medicine · April 10, 2018 Background: Clinical practice guidelines state that mobility is supposed to play an important role in determining use and duration of pharmacologic VTE prophylaxis. This study examines whether measured mobility levels relate to pharmacologic VTE prophylaxi ... Open Access Link to item Cite

Impact of hearing and visual impairment in older adults with cancer.

Conference Journal of Clinical Oncology · May 20, 2017 10036 Background: Hearing and visual impairment increase the risk of psychological, functional, and cognitive deficits in older adults. However, little is known about their impact in older patients (pts) with cancer. Methods: Thi ... Full text Cite

Toxicities and Related Outcomes of Elderly Patients (pts) (≥65 Years) with Hematologic Malignancies in the Contemporary Era (Alliance A151611)

Conference Blood · December 2, 2016 AbstractBackground: Contemporary approaches to non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) incorporate chemo-immunotherapy, biologic combinations, and immune modulating agents; toxiciti ... Full text Cite

Automated versus manual data extraction of venous thromboembolism risk among hospitalized older adults

Conference Journal of the American Geriatrics Society, Special Issue 2016: Annual Scientific Meeting Abstract Book · April 22, 2016 Full text Link to item Cite

Abstract P5-15-07: Association of patient preference for adjuvant chemotherapy (chemo) at baseline (BL) with toxicity, mental health, function, quality of life (QoL) and survival in older women with early stage breast cancer (ESBC) [CALGB 49907 Alliance]

Conference Cancer Research · May 1, 2015 AbstractBackground: In CALGB-49907 (NEJM 2009;360:2055), older patients (pts) with ESBC were randomized to standard adjuvant chemo (AC or CMF versus capecitabine). The objective of this secondary QoL analysi ... Full text Cite

The Impact of Anemia on Mortality, Cognition and Function in a Racially Diverse Community-Dwelling Elderly Population.

Conference Blood · November 16, 2004 AbstractThe WHO definition of anemia, Hgb<12g/dL (W) and <13g/dL (M) is largely based on studies in younger populations. As our population is aging it is important to explore the impact of varying Hgb ... Full text Cite

ALTERNATIVE APPROACHES TO THERAPY AFTER PLATEAU IN MULTIPLE-MYELOMA

Conference PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH · January 1, 1981 Link to item Cite

LONG-TERM EVALUATION OF PROGNOSTIC FACTORS IN BCNU, CYCLOPHOSPHAMIDE, PREDNISONE (BCP) TREATMENT OF MYELOMA

Conference PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH · January 1, 1977 Link to item Cite

BCNU, CYCLOPHOSPHAMIDE, AND PREDNISONE (BCP) VS MELPHALAN AND PREDNISONE (MP) IN MYELOMA

Conference PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH · 1976 Link to item Cite